Medical management of nerve gas intoxication: Guidelines for acute care of victims of terrorism;Nervegass - Retningslinjer ved terror

Tidsskrift for den Norske Laegeforening

Volumn 125, Issue 6, 2005, Pages 731-735

  Aas, Pål ^a,b   Jacobsen, Dag ^c  

^a NORWEGIAN DEFENCE RESEARCH ESTABLISHMENT FFI   (Norway)

^b UNIVERSITY OF BERGEN   (Norway)

^c ULLEVÅL UNIVERSITY HOSPITAL   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDOTE; ATROPINE; BENZODIAZEPINE; BOTULINUM TOXIN; CYANIDE; DIAZEPAM; METHYLPHOSPHONOTHIOIC ACID S (2 DIISOPROPYLAMINOETHYL) O ETHYL ESTER; MIDAZOLAM; NERVE GAS; OBIDOXIME; PRALIDOXIME; RICIN; SARIN; SAXITOXIN; SOMAN; TABUN; CHEMICAL WARFARE AGENT;

ACUTE TOXICITY; CHEMICAL WARFARE; CLINICAL PRACTICE; DEVICE; HEALTH CARE PERSONNEL; HUMAN; INTOXICATION; LD 50; NEUROTOXICITY; PRACTICE GUIDELINE; REVIEW; SELF INJECTION; TERRORISM; TRAINING; VICTIM; DISASTER PLANNING; GAS POISONING; WASTE MANAGEMENT;

ANTIDOTES; CHEMICAL WARFARE AGENTS; DECONTAMINATION; DISASTER PLANNING; GAS POISONING; GUIDELINES; HUMANS; TERRORISM;

EID: 15744372981     PISSN: 00292001     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (30)

1. Kjemivåpenkonvensjonen, 1997. Lov nr. 10, 6. mai 1994. Lov om gjennomføring av konvensjon om forbud mot utvikling, produksjon, lagring og bruk av kjemiske våpen samt ødeleggelse av dem.
2. Organisation for the Prohibition of Chemical Weapons: www.OPCW.org (26.1.2005).
3. Biologivåpenkonvensjonen, 1975. Convention on the prohibition of the development, production and stockpiling of bacteriological (biological) and toxin weapons and on their destruction. I: Arms control and disarmaments. Washington D.C.: US Arms Control and Disarmament Agency, 1990: 133-7.
4. Aas P. Biologiske og kjemiske våpen - hva er trusselen? Militær Teknikk 1999; 2-3: 46-52.
5. Waters L. Chemical weapons in the Iran/Iraq War. Military Review 1990; 70: 57-63.
6. Aas P. Håndteringen av en avtalebryter. UNSCOMs og IAEAs nedrustning av Iraks masseødeleggelsesvåpen. Internasjonal Politikk 1997; 1: 41-60.
7. Aas P. Biologiske og kjemiske våpen - hvor farlige er de? Oslo: NRK P2-akademiet, 2002: 137-49.
8. Otomi S, Takase M, Kumagai F. Sarin poisoning in Japan: a clinical experience in Japan Self Defence Force (JSDF) Central Hospital. Int Review of the Armed Forces Medical Services 1996; 69 (suppl 4/5/6): 97-102.
9. NATO Handbook on the medical Aspects of NBC Defence Operations AmedP-6. Unclassified, February 1997, Part III Chemical. Brussel: NATO Headquarters, 1997.
10. Lie B, Jacobsen D, Strømme JH et al. Organofosfatforgiftning. Tidsskr Nor Lægeforen 1990; 110: 3006-8.
11. Zajtchuk R, Bellamy RF. Textbook of military medicine: medical aspects of chemical and biological warfare. Washington D.C.: The Surgeon General at TTM Publications, Bordon Institute, Walter Reed Army Medical Center, 1997.
12. Johnson MK, Jacobsen D, Meredith TJ. Evaluation of antidotes for poisoning by organophosphorous pesticides. Emerg Med 2000; 12: 22-37.
13. Aas P. Future considerations for the medical management of nerve-agent intoxication. Prehospital Disaster Med 2003; 18: 208-16.
14. Leadbeater L, Inns RH, Rylands JM. Treatment of poisoning by soman. Fundam Appl Toxicol 1985; 5: S225-31.
15. Gall D. The use of therapeutic mixtures in the treatment of cholinesterase inhibition. Fundam Appl Toxicol 1981; 1: 214-6.
16. Abraham RB. Practical guidelines for acute care of victims of bioterrorism: conventional injuries and concomitant nerve agent intoxication. Anesthesiology 2002; 97: 989-1004.
17. Behandling av forgiftning med nervegasser. Oslo: Giftinformasjonen, 2004.
18. Faglige meddelelser fra Sanitetssjefen. Behandling av stridsgass-skader 1980; FAN P 1-2, Haaren DU 12-7-2. Oslo: Forsvarets overkommando, 1980.
19. Lallement G, Dorandeu F, Filliat P et al. Medical management of organophosphate-induced seizures. J Physiol (Paris) 1998; 92: 369-73.
20. McDonough JH, Zoeffel LD, McMonagle J et al. Anticonvulsant treatment of nerve agent seizures: anticholinergics versus diazepam in soman-intoxicated guinea pigs. Epilepsy Res 2000; 38: 1-14.
21. Aas P, Veiteberg T, Fonnum F. In vitro effects of soman on bronchial smooth muscle. Biochem Pharmacol 1986; 35 (suppl 11): 1793-9.
22. Hopmann G, Wanke H. Severe organophosphate poisoning. Dtsch Med Wochenschr 1974; 99: 2106-8.
23. Eddleston M, Buckley NA, Checketts H et al. Speed of initial atropinisation in significant organophosphorus pesticide poisoning - a systematic comparison of recommended regimens. Clin Toxicol 2004; 42: 865-75.
24. Holstege CP, Kirk M, Sidell FR. Chemical warfare nerve agent poisoning. Crit Care Clin 1997; 13: 923-42.
25. Dawson RM. Review of oximes available for treatment of nerve agent poisoning. J Appl Toxicol 1994; 14 (suppl 5): 317-31.
26. Aas P, Myhrer T. Aktuelle motmidler mot hjerneskader ved nervegassforgiftning. FFI/Rapport-2003/01278. Kjeller: Forsvarets forskningsinstitutt, 2003.
27. Norges offentlige utredninger. Et sårbart samfunn. Utfordringer for sikkerhets- og sårbarhetsarbeidet i samfunnet. NOU 2000: 24. Oslo: Statens forvaltningstjeneste, Seksjon statens trykning, 2000: 140-55.
28. Wetherell J. Continuous administration of low dose rates of physostigmine and hyoscine to guinea-pigs prevents the toxicity and reduces the incapacitation produced by soman poisoning. J Pharm Pharmacol 1994; 46: 1023-8.
29. Myhrer T, Enger S, Aas P. Cognitive side effects in rats caused by pharmacological agents used to prevent soman-induced lethality. Eur J Pharmacol 2004; 483: 271-9.
30. Myhrer T, Skymoen LR, Aas P. Pharmacological agents, hippocampal EEG, and anticonvulsant effects on soman-induced seizures in rats. Neurotoxicol 2003; 24: 357-67.